Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine R Tuttle

Showing results (11-20 of 355) with videos related to

Pageof 36
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|November 13, 2004
Cardiovascular implications of albuminuriaKatherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|April 28, 2022
Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 InhibitorKatherine R Tuttle
Nature Reviews. Nephrology|August 8, 2020
Impact of the COVID-19 pandemic on clinical researchKatherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2010
Charting new territory by simulated modeling of a clinical trialKatherine R Tuttle
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002
Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic renal artery stenosisKatherine R Tuttle
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2005
Renal manifestations of the metabolic syndromeKatherine R Tuttle
Lancet (London, England)|April 19, 2019
A turning point for chronic kidney disease in diabetesKatherine R Tuttle
The New England Journal of Medicine|June 25, 2021
Breaking New Ground with Incretin Therapy in DiabetesKatherine R Tuttle
Nature Clinical Practice. Endocrinology & Metabolism|October 8, 2008
Could renin inhibition be the next step forward in the treatment of diabetic kidney disease?Katherine R Tuttle
The Lancet. Diabetes & Endocrinology|December 18, 2020
SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyondKatherine R Tuttle
Pageof 36

Showing results (11-20 of 355) with videos related to

Sort By:
Pageof 36
Journal of Clinical Hypertension (Greenwich, Conn.)|November 13, 2004
Cardiovascular implications of albuminuriaKatherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|April 28, 2022
Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 InhibitorKatherine R Tuttle
Nature Reviews. Nephrology|August 8, 2020
Impact of the COVID-19 pandemic on clinical researchKatherine R Tuttle
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2010
Charting new territory by simulated modeling of a clinical trialKatherine R Tuttle
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 5, 2002
Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic renal artery stenosisKatherine R Tuttle
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 17, 2005
Renal manifestations of the metabolic syndromeKatherine R Tuttle
Lancet (London, England)|April 19, 2019
A turning point for chronic kidney disease in diabetesKatherine R Tuttle
The New England Journal of Medicine|June 25, 2021
Breaking New Ground with Incretin Therapy in DiabetesKatherine R Tuttle
Nature Clinical Practice. Endocrinology & Metabolism|October 8, 2008
Could renin inhibition be the next step forward in the treatment of diabetic kidney disease?Katherine R Tuttle
The Lancet. Diabetes & Endocrinology|December 18, 2020
SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyondKatherine R Tuttle
Pageof 36